Swiss Re markets latest Vita IV extreme mortality bond
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
  • Free trial
  • Log in

Swiss Re markets latest Vita IV extreme mortality bond

11 October 2010
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email

Investor appetite for extreme mortality exposure is about to be tested with a new offering of notes under Swiss Re's long-standing Vita series of transactions.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News ILS
Gift this article